Nelson Robert P, Ballow Mark
Division of Hematology/Oncology, Hematological Malignancy Program/Immunology, Indiana University School of Medicine, 55 Barnhill Drive, Ste 473, Indianapolis, IN 46202, USA.
J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S720-43. doi: 10.1067/mai.2003.146.
The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppressive therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies. The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.
本入门教材的前几章概述了免疫反应,为理解免疫调节和免疫治疗的潜在作用位点提供了背景知识。参与免疫反应的各种细胞群会释放多种可溶性生长和激活因子。它们在免疫反应的启动、传播和调节中发挥着至关重要的作用。药理免疫调节剂包括抑制性和刺激性药物。免疫抑制疗法包括抗代谢物、细胞毒性药物、辐射、肾上腺皮质糖皮质激素、免疫亲和素和治疗性抗体。临床免疫刺激领域正在成为治疗多种免疫缺陷疾病、慢性病毒感染和癌症的重要治疗方式。将从一般原则、分子靶点、主要适应症和不良反应等方面对这些化合物进行讨论。